Crinetics

Biotech M&A

Merger Announcement: Vertex to Acquire Crinetics at $85 a Share

Vertex Pharmaceuticals' July 2026 merger announcement set an $85 per share cash deal for Crinetics. The deal closed September 1 at about $10.0 billion.